2005
DOI: 10.1093/rheumatology/keh489
|View full text |Cite
|
Sign up to set email alerts
|

HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian women

Abstract: An increase of DRB1*11 in SSc is consistent with other reports. Although present in both diffuse and limited SSc disease subsets, the increase was predominantly due to over-representation of DRB1*1104 in women with diffuse SSc. Women with limited SSc had a preponderance of DRB1*1101, the most common allele in healthy women. DRB1*1104 and DRB1*1101 differ by a single amino acid at position 86, where the former has valine and the latter glycine.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
23
2
1

Year Published

2007
2007
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(29 citation statements)
references
References 27 publications
3
23
2
1
Order By: Relevance
“…Our results did not support the previous reports of a higher skin score in the presence of the HLA-B*62, DRB1*11, and DRB1*07 alleles [4, 9]. …”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…Our results did not support the previous reports of a higher skin score in the presence of the HLA-B*62, DRB1*11, and DRB1*07 alleles [4, 9]. …”
Section: Discussioncontrasting
confidence: 99%
“…Considering the clinical features, the HLA-DRB1 allele has been associated with the limited cutaneous form (lcSSc) [4] and B*62, DRB1*11 (DRB1*1104), and DRB1*07 with the diffuse cutaneous form (dcSSc) [4, 9]. An association between HLA alleles and visceral involvement in SSc is not well established.…”
Section: Introductionmentioning
confidence: 99%
“…Comparing SSc patients with healthy controls, the overall distribution of 3rd HVR sequences was significantly different ( p  = 0.007) (Table 2). The sequence “FLEDRRAA” (sequence category 5 in Table 1) was significantly enriched in SSc patients compared with controls ( p  = 0.004, p value corrected for multiple comparisons p c  = 0.032), primarily due to enrichment of DRB1*11:04 among SSc patients, as reported previously [3]. The sequence “FLEDRRAL” (sequence category 11 in Table 1) was also enriched in SSc patients ( p  = 0.006, p c  = 0.048) (Table 2), due to some increase of DRB1*08:01 and DRB1*08:02 in SSc patients.…”
Section: Resultssupporting
confidence: 78%
“…Clinical characteristics of the patients and controls have been published elsewhere. ( 12,13 ) The ethics review boards at the participating institutions approved the study protocol. Informed consent was obtained from all subjects.…”
Section: Methodsmentioning
confidence: 99%